Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis

Clinical trial NCT01925768 · COMPLETED

Trial details

NCT number: NCT01925768
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2013-09-04
Primary completion: 2015-02-25
Enrollment: 219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.